AXISCADES Technologies Limited (NSE:AXISCADES)

Theseus Pharmaceuticals Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 1, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	54,405	37,755	23,185	10,232	4,821	1,507
Market Cap Growth	62.84%	62.84%	126.60%	112.24%	219.98%	43.53%
Enterprise Value	55,636	39,117	26,523	11,285	4,654	1,437
Last Close Price	1280.70	892.30	553.15	267.50	126.25	39.80
PE Ratio	72.60	50.38	70.67	-	21.68	-
PS Ratio	5.28	3.66	2.43	1.25	0.79	0.29
PB Ratio	8.30	5.76	3.92	2.98	1.43	0.50
P/TBV Ratio	11.75	8.15	5.91	5.16	2.53	0.95
P/FCF Ratio	107.85	74.84	39.58	17.12	27.45	1.29
P/OCF Ratio	61.58	42.74	29.37	14.49	15.46	1.23
EV/Sales Ratio	5.40	3.80	2.78	1.37	0.76	0.27
EV/EBITDA Ratio	39.06	27.46	22.50	8.42	7.98	2.94
EV/EBIT Ratio	54.11	38.03	25.49	9.23	9.82	3.62
EV/FCF Ratio	110.29	77.54	45.27	18.89	26.50	1.23
Debt / Equity Ratio	0.39	0.39	0.54	1.01	0.21	0.34
Debt / EBITDA Ratio	1.81	1.81	2.36	2.36	1.02	1.67
Debt / FCF Ratio	5.11	5.11	5.44	5.79	4.10	0.89
Asset Turnover	0.91	0.91	0.94	0.97	0.79	0.65
Inventory Turnover	11.21	11.21	10.28	9.35	11.63	17.34
Quick Ratio	1.53	1.53	1.54	1.19	0.75	0.95
Current Ratio	2.22	2.22	1.92	1.50	0.99	1.07
Return on Equity (ROE)	12.07%	12.07%	7.14%	-1.41%	7.09%	-6.81%
Return on Assets (ROA)	5.67%	5.67%	6.36%	9.00%	3.85%	3.10%
Return on Capital (ROIC)	7.05%	7.05%	8.13%	13.92%	7.25%	5.51%
Return on Capital Employed (ROCE)	12.30%	12.30%	13.10%	22.40%	13.20%	9.90%
Earnings Yield	1.38%	1.98%	1.42%	-0.51%	4.61%	-14.38%
FCF Yield	0.93%	1.34%	2.53%	5.84%	3.64%	77.30%
Payout Ratio	-	-	1.32%	-	-	-
Buyback Yield / Dilution	-2.67%	-2.67%	-11.38%	1.46%	-2.28%	2.44%

Updated Feb 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.